These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22000171)

  • 1. Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma?
    Glant JA; Waters JA; House MG; Zyromski NJ; Nakeeb A; Pitt HA; Lillemoe KD; Schmidt CM
    Surgery; 2011 Oct; 150(4):607-16. PubMed ID: 22000171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
    J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Second-look operation in pancreatic carcinoma previously assessed as unresectable].
    Warnick P; Bahra M; Andreou A; Neuhaus P; Glanemann M
    Zentralbl Chir; 2010 Feb; 135(1):70-4. PubMed ID: 20162503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma.
    Chu CK; Mazo AE; Goodman M; Egnatashvili V; Sarmiento JM; Staley CA; Galloway JR; Adsay NV; Jacobs S; Kooby DA
    Ann Surg Oncol; 2010 Feb; 17(2):502-13. PubMed ID: 19885697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma.
    Lee JK; Kim AY; Kim PN; Lee MG; Ha HK
    Eur J Radiol; 2010 Feb; 73(2):310-6. PubMed ID: 19070981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic head resection with segmental duodenectomy: safety and long-term results.
    Nakao A; Fernández-Cruz L
    Ann Surg; 2007 Dec; 246(6):923-8; discussion 929-31. PubMed ID: 18043093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
    Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
    J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
    Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
    Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.
    Van den Broeck A; Sergeant G; Ectors N; Van Steenbergen W; Aerts R; Topal B
    Eur J Surg Oncol; 2009 Jun; 35(6):600-4. PubMed ID: 19131205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma].
    Xie YB; Zhao P; Wang CF; Shan Y; Zhao DB; Liu Q; Bai XF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):686-9. PubMed ID: 19173911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?
    Kooby DA; Hawkins WG; Schmidt CM; Weber SM; Bentrem DJ; Gillespie TW; Sellers JB; Merchant NB; Scoggins CR; Martin RC; Kim HJ; Ahmad S; Cho CS; Parikh AA; Chu CK; Hamilton NA; Doyle CJ; Pinchot S; Hayman A; McClaine R; Nakeeb A; Staley CA; McMasters KM; Lillemoe KD
    J Am Coll Surg; 2010 May; 210(5):779-85, 786-7. PubMed ID: 20421049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma.
    Welsch T; Keleg S; Bergmann F; Bauer S; Hinz U; Schmidt J
    Pancreas; 2009 Nov; 38(8):968-76. PubMed ID: 19672209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure during pancreatic surgery. Do we have to examine the falciform and round ligaments for pancreatic cancer metastasis?
    Ben-Ishay O; Ariche A; Lachter J; Kluger Y
    JOP; 2011 Mar; 12(2):145-8. PubMed ID: 21386640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pictorial essay: multimodality imaging of metastases from pancreatic ductal adenocarcinoma.
    Ozkan E; Balachandran A; Bhosale PR; Tamm EP; Marcal LP; Szklaruk J
    Clin Imaging; 2010; 34(4):277-87. PubMed ID: 20630340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most pancreatic cancer resections are R1 resections.
    Esposito I; Kleeff J; Bergmann F; Reiser C; Herpel E; Friess H; Schirmacher P; Büchler MW
    Ann Surg Oncol; 2008 Jun; 15(6):1651-60. PubMed ID: 18351300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic evaluation and staging of pancreatic ductal adenocarcinoma.
    McIntyre CA; Winter JM
    Semin Oncol; 2015 Feb; 42(1):19-27. PubMed ID: 25726049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of giant cell carcinoma of the pancreas.
    Zou XP; Yu ZL; Li ZS; Zhou GZ
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):300-2. PubMed ID: 15138131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstaging chemotherapy and alteration in the classic computed tomography/magnetic resonance imaging signs of vascular involvement in patients with pancreaticobiliary malignant tumors: influence on patient selection for surgery.
    Donahue TR; Isacoff WH; Hines OJ; Tomlinson JS; Farrell JJ; Bhat YM; Garon E; Clerkin B; Reber HA
    Arch Surg; 2011 Jul; 146(7):836-43. PubMed ID: 21768431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.